CVKD
Cadrenal Therapeutics, Inc.

6,003
Mkt Cap
$17.12M
Volume
56,731.00
52W High
$22.90
52W Low
$6.42
PE Ratio
-0.86
CVKD Fundamentals
Price
$6.93
Prev Close
$7.32
Open
$7.46
50D MA
$10.23
Beta
0.97
Avg. Volume
80,946.14
EPS (Annual)
-$8.73
P/B
5.22
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Matthew Szot Sells 9,933 Shares of Cadrenal Therapeutics (NASDAQ:CVKD) Stock
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD - Get Free Report) CFO Matthew Szot sold 9,933 shares of the company's stock in a transaction dated Monday, December 29th. The shares were sold at an average...
MarketBeat·6d ago
News Placeholder
Why the underdog mindset could be your business superpower
You can catch Warrior Money on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts. What does it take to go from refugee kid to Marine pilot, biotech CEO, and author? On this...
Yahoo! Finance-YouTube·2mo ago
News Placeholder
Cadrenal Therapeutics, Inc.
CVKD: Acquires Factor XIa Inhibitors
Zacks·2mo ago
News Placeholder
Cadrenal Therapeutics Expands Pipeline With Portfolio Acquisition Worth Up To $15 Million
The company said that the acquisition will significantly enhance its pipeline by adding novel assets in acute and chronic anticoagulation settings.
Stocktwits·4mo ago
<
...
1
>

Latest CVKD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.